Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd. ("Intas Pharmaceuticals"), focused on the ...

Exposure to TNF inhibitors was linked to a reduced risk for cardiovascular events among patients with AS; the impact of IL-17 inhibitors was less clear.

GUANGZHOU, China I 7, 2025 I Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative ...

Patients with ankylosing spondylitis and IBD exhibit distinct clinical and radiographic features, compared against those without comorbid IBD.

A study found a potential causal link between rheumatoid arthritis and increased prostate cancer risk. Researchers used ...

Montrealer Michael Santillo was 29 when he was diagnosed with ankylosing spondylitis, a type of inflammatory arthritis. It ...

An 81-year-old man with longstanding ankylosing spondylitis presented to the emergency department with pain in his lower back 2 days after a fall from standing height. The pain from the injury made it ...

A new study suggests that genetically predicted rheumatoid arthritis (RA) may increase the risk of developing prostate cancer ...

A recent study finds that genetically predicted rheumatoid arthritis is causally associated with prostate cancer.

A project based in a Nottinghamshire town is helping the community by getting young people hooked on fishing. Mending Lines ...

Alvotech and Teva announced FDA acceptance of the Biologics License Application (BLA) for AVT05, a proposed biosimilar ...

Discover how biologic therapies impact infection risks in ankylosing spondylitis (AS) patients. A KOBIO registry study ...